Acquired hemophilia A treated with rituximab in a 62-year-old female with rheumatoid arthritis: a case-based review
Acquired hemophilia A (AHA) is a rare autoimmune disorder with unpredictable hemostasis that is caused by autoantibody formation against coagulation factor VIII. AHA can occur in the context of autoimmune inflammatory rheumatic disorders. Here we report the case of a 62-year-old female with an 11-ye...
Saved in:
Main Authors: | D. Mohamadzadeh (Author), S. Assar (Author), F. Farsad (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of rituximab in rheumatoid arthritis
by: F. Atzeni, et al.
Published: (2011) -
Rituximab for the treatment of rheumatoid arthritis: an update
by: Mok CC
Published: (2013) -
A case of acquired hemophilia A in an elderly female
by: Kiranveer Kaur, et al.
Published: (2018) -
Adherence to treatment and associated factors in rheumatoid arthritis patients: a cross-sectional study from Iran
by: D. Mohamadzadeh, et al.
Published: (2023) -
Disseminated cutaneous herpes simplex infection after COVID-19 vaccination in a rheumatoid arthritis patient: a case report and review
by: D. Mohamadzadeh, et al.
Published: (2022)